Empowered Funds
FULC icon

Empowered Funds’s Fulcrum Therapeutics FULC Stock Holding History

Empowered Funds’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$329K Buy
+89,046
New +$334K ﹤0.01% 1996

Other funds holding FULC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Empowered Funds's FULC Position: Q3 2026 in Review

Empowered Funds opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 89,046 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #1996 among its holdings.

97 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Empowered Funds held 89,046 shares of Fulcrum Therapeutics worth $329K as of Q3 2026.
  • Fulcrum Therapeutics was a new Empowered Funds position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1996 holding.
  • 97 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.